Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis

Life Sciences

Volumn 80, Issue 22, 2007, Pages 2036-2044

  Yamaguchi, Shohei ^a   Kawanaka, Hirofumi ^a   Yoshida, Daisuke ^a   Maehara, Yoshihiko ^a   Hashizume, Makoto ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

eNOS; Liver cirrhosis; Portal hypertension; Spleen; Splenic hemodynamics

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT INJURY; BLOOD VESSEL OCCLUSION; CONTROLLED STUDY; DOPPLER FLOWMETER; DRUG MECHANISM; HEMODYNAMICS; LIVER CIRRHOSIS; LIVER CONGESTION; MALE; MICROCIRCULATION; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION; PORTAL HYPERTENSION; RAT; SPECTROPHOTOMETER; SPLEEN; SPLEEN BLOOD FLOW;

ANIMALS; BLOOD FLOW VELOCITY; HYPERTENSION, PORTAL; LASER-DOPPLER FLOWMETRY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; NITRIC OXIDE SYNTHASE TYPE III; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 34247644343     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.03.009     Document Type: Article

References (55)

1. Abraldes J.G., Iwakiri Y., Loureiro-Silva M., Haq O., Sessa W.C., and Groszmann R.J. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. American Journal of Physiology: Gastrointestinal and Liver Physiology 290 5 (2006) G980-G987
2. Almond N.E., and Wheatley A.M. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. The American Journal of Physiology 262 2 Pt 1 (1992) G203-G209
3. Arvidsson D., Svensson H., and Haglund U. Laser-Doppler flowmetry for estimating liver blood flow. The American Journal of Physiology 254 4 Pt 1 (1988) G471-G476
4. Barsacchi R., Perrotta C., Bulotta S., Moncada S., Borgese N., and Clementi E. Activation of endothelial nitric-oxide synthase by tumor necrosis factor-alpha: a novel pathway involving sequential activation of neutral sphingomyelinase, phosphatidylinositol-3′ kinase, and Akt. Molecular Pharmacology 63 4 (2003) 886-895
5. Bolognesi M., Merkel C., Sacerdoti D., Nava V., and Gatta A. Role of spleen enlargement in cirrhosis with portal hypertension. Digestive and Liver Disease 34 2 (2002) 144-150
6. Busse R., and Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Letters 265 1-2 (1990) 133-136
7. Cahill P.A., Foster C., Redmond E.M., Gingalewski C., Wu Y., and Sitzmann J.V. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology 22 2 (1995) 598-606
8. Cahill P.A., Redmond E.M., Hodges R., Zhang S., and Sitzmann J.V. Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats. Journal of Hepatology 25 3 (1996) 370-378
9. Chen Y.C., Gines P., Yang J., Summer S.N., Falk S., Russell N.S., and Schrier R.W. Increased vascular heme oxygenase-1 expression contributes to arterial vasodilation in experimental cirrhosis in rats. Hepatology 39 4 (2004) 1075-1087
10. Diez-Ruiz A., Tilz G.P., Gutierrez-Gea F., Gil-Extremera B., Murr C., Wachter H., and Fuchs D. Neopterin and soluble tumor necrosis factor receptor type I in alcohol-induced cirrhosis. Hepatology 21 4 (1995) 976-978
11. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., and Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399 6736 (1999) 601-605
12. Fernandez M., Vizzutti F., Garcia-Pagan J.C., Rodes J., and Bosch J. Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology 126 3 (2004) 886-894
13. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nature Medicine 9 6 (2003) 669-676
14. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circulation Research 82 6 (1998) 686-695
15. Forstermann U., Pollock J.S., Schmidt H.H., Heller M., and Murad F. Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 88 5 (1991) 1788-1792
16. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 6736 (1999) 597-601
17. Gadano A.C., Sogni P., Yang S., Cailmail S., Moreau R., Nepveux P., Couturier D., and Lebrec D. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats. Journal of Hepatology 26 3 (1997) 678-686
18. Gitlin N., Grahame G.R., Kreel L., Williams H.S., and Sherlock S. Splenic blood flow and resistance in patients with cirrhosis before and after portacaval anastomoses. Gastroenterology 59 2 (1970) 208-213
19. Gupta T.K., Toruner M., Chung M.K., and Groszmann R.J. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 28 4 (1998) 926-931
20. Ishikawa H., Jin M.B., Ogata T., Taniguchi M., Suzuki T., Shimamura T., Magata S., Horiuchi H., Ogata K., Masuko H., Fujita M., Furukawa H., and Todo S. Role of cyclic nucleotides in ischemia and reperfusion injury of canine livers. Transplantation 73 7 (2002) 1041-1048
21. Kawada N., Tran-Thi T.A., Klein H., and Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. European Journal of Biochemistry/FEBS 213 2 (1993) 815-823
22. Kawanaka H., Jones M.K., Szabo I.L., Baatar D., Pai R., Tsugawa K., Sugimachi K., Sarfeh I.J., and Tarnawski A.S. Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI3-kinase-Akt signaling pathway. Hepatology 35 2 (2002) 393-402
23. Kilbourn R.G., and Belloni P. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin. Journal of the National Cancer Institute 82 9 (1990) 772-776
24. Kountouras J., Billing B.H., and Scheuer P.J. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. British Journal of Experimental Pathology 65 3 (1984) 305-311
25. Lee F.Y., Lu R.H., Tsai Y.T., Lin H.C., Hou M.C., Li C.P., Liao T.M., Lin L.F., Wang S.S., and Lee S.D. Plasma interleukin-6 levels in patients with cirrhosis. Relationship to endotoxemia, tumor necrosis factor-α and hyperdynamic circulation. Scandinavian Journal of Gastroenterology 31 5 (1996) 500-505
26. Liu H., Song D., and Lee S.S. Increased nitric oxide synthase expression in aorta of cirrhotic rats. Life Sciences 64 19 (1999) 1753-1759
27. Lopez-Talavera J.C., Merrill W.W., and Groszmann R.J. Tumor necrosis factor alpha: a major contributor to the hyperdynamic circulation in prehepatic portal-hypertensive rats. Gastroenterology 108 3 (1995) 761-767
28. Lopez-Talavera J.C., Cadelina G., Olchowski J., Merrill W., and Graszmann R.J. Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 23 6 (1996) 1616-1621
29. Manenti F., and Williams R. Injection studies of the splenic vasculature in portal hypertension. Gut 7 2 (1966) 175-180
30. Manenti A., Botticelli A., Gibertini G., and Botticelli L. Experimental congestive splenomegaly: histological observations in the rat. Pathologica 85 1100 (1993) 721-724
31. Martin P.Y., Xu D.L., Niederberger M., Weigert A., Tsai P., St John J., Gines P., and Schrier R.W. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. The American Journal of Physiology 270 3 Pt 2 (1996) F494-F499
32. Merkel C., Gatta A., Arnaboldi L., and Zuin R. Splenic haemodynamics and portal hypertension in patients with liver cirrhosis and spleen enlargement. Clinical Physiology (Oxford, England) 5 6 (1985) 531-539
33. Michell B.J., Griffiths J.E., Mitchelhill K.I., Rodriguez-Crespo I., Tiganis T., Bozinovski S., de Montellano P.R., Kemp B.E., and Pearson R.B. The Akt kinase signals directly to endothelial nitric oxide synthase. Current Biology: CB 9 15 (1999) 845-848
34. Moncada S., Palmer R.M., and Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacological Reviews 43 2 (1991) 109-142
35. Morales-Ruiz M., Jimenez W., Prez-Sala D., Ros J., Leivas A., Lamas S., Rivera F., and Arroyo V. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Hepatology 24 6 (1996) 1481-1486
36. Morales-Ruiz M., Cejudo-Martin P., Fernandez-Varo G., Tugues S., Ros J., Angeli P., Rivera F., Arroyo V., Rodes J., Sessa W.C., and Jimenez W. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats. Gastroenterology 125 2 (2003) 522-531
37. Niederberger M., Gines P., Martin P.Y., Tsai P., Morris K., McMurtry I., and Schrier R.W. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Hepatology 24 4 (1996) 947-951
38. Ohta M., Tarnawski A., Itani R., Pai R., Tomikawa M., Sugimachi K., and Sarfeh I.J. Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats. Hepatology 27 4 (1998) 906-913
39. Panes J., Perry M.A., Anderson D.C., Muzykantov V.R., Carden D.L., Miyasaka M., and Granger D.N. Portal hypertension enhances endotoxin-induced intercellular adhesion molecule 1 up-regulation in the rat. Gastroenterology 110 3 (1996) 866-874
40. Rocky D.C., and Chung J.J. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. The Journal of Clinical Investigation 95 3 (1995) 1199-1206
41. Rocky D.C., and Chung J.J. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 114 2 (1998) 344-351
42. Sarela A.I., Mihaimeed F.M., Batten J.J., Davidson B.R., and Mathie R.T. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 44 5 (1999) 749-753
43. Shah S.H., Hayes P.C., Allan P.L., Nicoll J., and Finlayson N.D. Measurement of spleen size and its relation to hypersplenism and portal hemodynamics in portal hypertension due to hepatic cirrhosis. The American Journal of Gastroenterology 91 12 (1996) 2580-2583
44. Shibuya K., Maruyama A., Hirakoba K., Maeda M., and Ogaki T. Does the regional oxygen uptake measured by near infrared spectroscopy reflect the phase II pulmonary oxygen uptake at the onset of exercise?. Journal of Physiological Anthropology and Applied Human Science 22 3 (2003) 137-142
45. Sztrymf B., Rabiller A., Nunes H., Savale L., Lebrec D., Le Pape A., de Montpreville V., Mazmanian M., Humbert M., and Herve P. Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 23 5 (2004) 752-758
46. Takagi K., Ashida H., and Utsunomiya J. The effect of splenomegaly on splanchnic hemodynamics in nonalcoholic cirrhosis after distal splenorenal shunt and splenopancreatic disconnection. Hepatology 20 2 (1994) 342-348
47. Tawadrous M.N., Zhang X.Y., and Wheatley A.M. Microvascular origin of laser-Doppler flux signal from the surface of normal and injured liver of the rat. Microvascular Research 62 3 (2001) 355-365
48. Tazi K.A., Moreau R., Herve P., Dauvergne A., Cazals-Hatem D., Bert F., Poirel O., Rabiller A., and Lebrec D. Norfloxacin reduces aortic NO synthases and proinflammatory cytokine up-regulation in cirrhotic rats: role of Akt signaling. Gastroenterology 129 1 (2005) 303-314
49. Tilg H., Wilmer A., Vogel W., Herold M., Nolchen B., Judmaier G., and Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103 1 (1992) 264-274
50. Westaby S., Wilkinson S.P., Warren R., and Williams R. Spleen size and portal hypertension in cirrhosis. Digestion 17 1 (1978) 63-68
51. Wiest R., and Groszmann R.J. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough. Hepatology 35 2 (2002) 478-491
52. Williams R., Condon R.E., Williams H.S., Blendis L.M., and Kreel K. Splenic blood flow in cirrhosis and portal hypertension. Clinical Science 34 3 (1968) 441-452
53. Witte C.L., Witte M.H., Renert W., and Corrigan Jr. J.J. Splenic circulatory dynamics in congestive splenomegaly. Gastroenterology 67 3 (1974) 498-505
54. Zhang J., Ling Y., Luo B., Tang L., Ryter S.W., Stockard C.R., Grizzle W.E., and Fallon M.B. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alteration in experimental hepatopulmonary syndrome. Gastroenterology 125 5 (2003) 1441-1451
55. Zwiebel W.J., Mountford R.A., Halliwell M.J., and Wells P.N. Splanchnic blood flow in patients with cirrhosis and portal hypertension: investigation with duplex Doppler US. Radiology 194 3 (1995) 807-812